Endothelial cells organize fibrin clots into structures that are more resistant to lysis

被引:16
作者
Jerome, WG
Handt, S
Hantgan, RR
机构
[1] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA
[3] Rhein Westfal TH Aachen, Inst Pathol, D-52072 Aachen, Germany
[4] Wake Forest Univ, Hlth Sci Ctr, Dept Biochem, Winston Salem, NC 27157 USA
关键词
thrombosis; fibrinolysis; fibrin; endothelial cells; integrins; confocal microscopy;
D O I
10.1017/S143192760505052X
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Acute myocardial infarction is a major cause of death and disability in the United States. Introducing thrombolytic agents into the clot to dissolve occlusive coronary artery thrombi is one method of treatment. However, despite advances in our knowledge of thrombosis and thrombolysis, survival rates following thrombolytic therapy have not improved substantially. This failure highlights the need for further study of the factors mediating clot stabilization. Using laser scanning confocal microscopy of clots formed from fluorescein-labeled fibrinogen, we investigated what effect binding of fibrin to the endothelial surface has on clot structure and resistance to lysis. Fluorescent fibrin clots were produced over human umbilical vein endothelial cells (HUVEC) and the clot structure analyzed. In the presence of HUVEC, fibrin near the endothelial surface was more organized and occurred in tighter bundles compared to fibrin just 50 mu m above. The HUVEC influence on fibrin architecture was blocked by inhibitory concentrations of antibodies to alpha(V) or 163 integrin subunits. The regions of the clots associated with endothelial cells were more resistant to lysis than the more homogenous regions distal to endothelium. Thus, our data show that binding of fibrin to integrins on endothelial surfaces produces clots that are more resistant to lysis.
引用
收藏
页码:268 / 277
页数:10
相关论文
共 34 条
[11]   ENDOTHELIAL-CELL ADHESIVE RECEPTORS [J].
DEJANA, E .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 21 :S18-S21
[12]   NEW STANDARD FOR SUCCESS OF THROMBOLYTIC THERAPY - AN EARNEST PROPOSAL [J].
FORRESTER, JS .
CIRCULATION, 1995, 92 (08) :2026-2028
[13]  
GROUP FC, 1994, LANCET, V343, P311
[14]   PAI-1 RELEASED FROM CULTURED HUMAN ENDOTHELIAL-CELLS DELAYS FIBRINOLYSIS AND IS INCORPORATED INTO THE DEVELOPING FIBRIN CLOT [J].
HANDT, S ;
JEROME, WG ;
BRAATEN, JV ;
LEWIS, JC ;
KIRKPATRICK, CJ ;
HANTGAN, RR .
FIBRINOLYSIS, 1994, 8 (02) :104-112
[15]   Plasminogen activator inhibitor-1 secretion by endothelial cells increases fibrinolytic resistance of an in vitro fibrin clot: Evidence for a key role of endothelial cells in thrombolytic resistance [J].
Handt, S ;
Jerome, WG ;
Tietze, L ;
Hantgan, RR .
BLOOD, 1996, 87 (10) :4204-4213
[17]  
Hantgan RR, 1998, THROMB HAEMOSTASIS, V79, P602
[18]   The need for wider utilization of thrombolytic therapy [J].
Hennekens, C .
CLINICAL CARDIOLOGY, 1997, 20 (11) :26-31
[19]   CULTURE OF HUMAN ENDOTHELIAL CELLS DERIVED FROM UMBILICAL VEINS - IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGICAL CRITERIA [J].
JAFFE, EA ;
NACHMAN, RL ;
BECKER, CG ;
MINICK, CR .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (11) :2745-2756
[20]  
Jerome WG, 1998, ENDOTHEL CELL RES S, V4, P93